Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.22.2
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of option activity
Weighted Weighted
Average Average
Number of Exercise Remaining Intrinsic
Options Price Term (Yrs) Value
Outstanding, January 1, 2022 2,415,000 $ 3.73
Granted
-
-
Exercised
-
-
Expired
-
-
Forfeited
-
-
Outstanding, March 31, 2022 2,415,000 $ 3.73 7.27 $
-
Exercisable, March 31, 2022 1,600,000 $ 3.80 6.57 $
-

Schedule of options outstanding and exercisable
Options Outstanding Options Exercisable
Weighted
Outstanding Average Exercisable
Exercise Number of Remaining Life Number of
Price Options In Years Options
$ 2.11 80,000 8.25 20,000
$ 2.17 120,000 8.35 120,000
$ 2.21 350,000 9.29 200,000
$ 2.48 160,000 9.10 40,000
$ 4.09 1,425,000 5.60 1,060,000
$ 5.66 280,000 7.47 160,000
2,415,000 6.57 1,600,000

Schedule of non-vested restricted common stock activity
Weighted
Number of Average
Restricted Grant Date
Stock Fair Value
Non-vested balance, January 1, 2022 80,000 $ 2.00
Vested (80,000 ) 2.00
Non-vested balance, March 31, 2022
-
 $
-